Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
UW solution (University of Wisconsin solution) is a multi-component organ preservation solution developed in 1986 by Belzer and Southard. It is widely regarded as the gold standard for hypothermic static cold storage of abdominal organs (kidney, liver, pancreas) intended for transplantation. The solution is a complex cocktail designed to minimize cell swelling and ischemia-reperfusion injury during storage. Key components include lactobionic acid (an impermeant anion providing osmotic support), raffinose (osmotic support), hydroxyethyl starch (colloid osmotic pressure), and various antioxidants and metabolic precursors like glutathione, allopurinol, and adenosine. It maintains an osmolarity of approximately 320 mOsm/L and a pH of 7.4, effectively reducing cellular edema and preserving organ viability for extended periods prior to transplantation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on UW solution.